TABLE 2.
Cross-tabulation between self-reported alcohol consumption and urinary EtG concentration among 6211 PREVEND participants using a cutoff value of 100 ng/mL1
| Interpretation of EtG concentration | |||
|---|---|---|---|
| Positive (≥100 ng/mL) | Negative (<100 ng/mL) | Total | |
| Self-reported alcohol consumption, n (%) | |||
| No | 118 (7.7) | 1421 (92.3) | 1539 |
| Yes | 3096 (66.3) | 1576 (33.7) | 4672 |
| Stratified by alcohol consumption category, n (%) | |||
| 1–4 units/mo | 319 (30.3) | 735 (69.7) | 1054 |
| 2–7 units/wk | 1265 (64.2) | 704 (35.8) | 1969 |
| 1–3 units/d | 1264 (91.5) | 117 (8.5) | 1381 |
| ≥4 units/d | 248 (92.5) | 20 (7.5) | 268 |
| Total, n (%) | 3214 (51.7) | 2997 (48.3) | 6211 |
1
EtG, ethyl glucuronide; PREVEND, Prevention of Renal and Vascular End-Stage Disease.